High body mass index and outcomes of dual antithrombotic therapy with dabigatran and a P2Y12 inhibitor in patients with atrial fibrillation undergoing PCI: Results from RE-DUAL PCI

26 August 2018 (15:50 - 16:40)
Organised by:
Congress Presentation Part of: Atrial fibrillation - General 2 Clinical ESC Premium Access ESC Congress 2018

ESC 365 is supported by

ESC 365 is supported by